
Reset all filters
01 3Gowling WLG (Canada) LLP
Reset all filters
01 32802102
Reset all filters
01 3GALCANEZUMAB
Reset all filters
01 3SOLUTION
Reset all filters
01 32031-06-07
Patent Expiration Date : 2031-06-07
Date Granted : 2016-07-26
Brand Name : EMGALITY
Patent Number : 2802102
Filing Date : 2011-06-07
Strength per Unit : 120 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2031-06-07
Date Granted : 2016-07-26
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2031-06-07
Date Granted : 2016-07-26
Brand Name : EMGALITY
Patent Number : 2802102
Filing Date : 2011-06-07
Strength per Unit : 120 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2031-06-07
Date Granted : 2016-07-26
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2031-06-07
Date Granted : 2016-07-26
Brand Name : EMGALITY
Patent Number : 2802102
Filing Date : 2011-06-07
Strength per Unit : 100 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2031-06-07
Date Granted : 2016-07-26
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF